FTSE All-Share
|
5 752,13
|
18,49
|
0,32 %
|
Analysen zu FTSE All-Share-Werten
| 14.09.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 14.09.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 14.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.09.26 | GSK Buy | Jefferies & Company Inc. | |
| 14.09.26 | Diageo Buy | Jefferies & Company Inc. | |
| 14.09.26 | BP Hold | Jefferies & Company Inc. | |
| 14.09.26 | Shell Buy | Jefferies & Company Inc. | |
| 14.09.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 11.09.26 | BAT Underperform | RBC Capital Markets | |
| 11.09.26 | Shell Buy | Goldman Sachs Group Inc. | |
| 11.09.26 | BP Buy | Goldman Sachs Group Inc. | |
| 10.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 10.09.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.09.26 | AstraZeneca Outperform | RBC Capital Markets | |
| 08.09.26 | GSK Sector Perform | RBC Capital Markets | |
| 08.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | BP Neutral | JP Morgan Chase & Co. | |
| 08.09.26 | Shell Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 08.09.26 | GSK Underweight | Barclays Capital | |
| 08.09.26 | AstraZeneca Overweight | Barclays Capital | |
| 07.09.26 | Unilever Outperform | Bernstein Research | |
| 07.09.26 | Unilever Hold | Deutsche Bank AG | |
| 07.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.09.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 04.09.26 | Shell Overweight | Barclays Capital | |
| 04.09.26 | BP Overweight | Barclays Capital | |
| 04.09.26 | Shell Sector Perform | RBC Capital Markets | |
| 04.09.26 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 04.09.26 | BP Outperform | RBC Capital Markets | |
| 02.09.26 | GSK Hold | Deutsche Bank AG | |
| 02.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 02.09.26 | BAT Buy | UBS AG | |
| 02.09.26 | Barclays Buy | Jefferies & Company Inc. | |
| 01.09.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.09.26 | Diageo Neutral | JP Morgan Chase & Co. | |
| 01.09.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 28.08.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 28.08.26 | Diageo Outperform | Bernstein Research |
HOT STOCKS DER LETZTEN 3 TAGE
| GSK | 3 |
| AstraZeneca | 2 |
| Diageo | 1 |
| BP | 1 |
| Shell | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.